IL133824A - Tetrazole derivatives and medicaments containing the same - Google Patents

Tetrazole derivatives and medicaments containing the same

Info

Publication number
IL133824A
IL133824A IL13382498A IL13382498A IL133824A IL 133824 A IL133824 A IL 133824A IL 13382498 A IL13382498 A IL 13382498A IL 13382498 A IL13382498 A IL 13382498A IL 133824 A IL133824 A IL 133824A
Authority
IL
Israel
Prior art keywords
same
medicaments containing
tetrazole derivatives
tetrazole
derivatives
Prior art date
Application number
IL13382498A
Other languages
English (en)
Other versions
IL133824A0 (en
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of IL133824A0 publication Critical patent/IL133824A0/xx
Publication of IL133824A publication Critical patent/IL133824A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13382498A 1997-07-25 1998-07-18 Tetrazole derivatives and medicaments containing the same IL133824A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97112792 1997-07-25
PCT/EP1998/004477 WO1999005111A1 (fr) 1997-07-25 1998-07-18 Nouveaux derives de tetrazole

Publications (2)

Publication Number Publication Date
IL133824A0 IL133824A0 (en) 2001-04-30
IL133824A true IL133824A (en) 2005-12-18

Family

ID=8227116

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13382498A IL133824A (en) 1997-07-25 1998-07-18 Tetrazole derivatives and medicaments containing the same

Country Status (17)

Country Link
US (1) US6410551B1 (fr)
EP (1) EP0998460B1 (fr)
JP (1) JP2001510825A (fr)
AT (1) ATE260899T1 (fr)
AU (1) AU753615B2 (fr)
CA (1) CA2297923A1 (fr)
CZ (1) CZ293725B6 (fr)
DE (1) DE69822162T2 (fr)
DK (1) DK0998460T3 (fr)
EE (1) EE04054B1 (fr)
ES (1) ES2217575T3 (fr)
HU (1) HUP0002510A3 (fr)
IL (1) IL133824A (fr)
PL (1) PL190685B1 (fr)
PT (1) PT998460E (fr)
SI (1) SI0998460T1 (fr)
WO (1) WO1999005111A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2241571T3 (es) * 1999-01-15 2005-11-01 Altana Pharma Ag N-oxidos de fenantrinida con actividad inhividora de pde-iv.
CA2360386A1 (fr) 1999-01-15 2000-07-20 Beate Gutterer 6-phenylphenanthridines polysubstitues a activite inhibant pde-iv
DE60020079T2 (de) 1999-01-15 2006-01-19 Altana Pharma Ag Phenanthridin-N-oxide mit PDE-IV-hemmender Wirkung
WO2000042019A1 (fr) 1999-01-15 2000-07-20 Byk Gulden Lomberg Chemische Fabrik Gmbh 6-arylphenanthridines a activite inhibant pde-iv
TR200501553T2 (tr) 1999-01-15 2005-06-21 Altana Pharma Ag PDE-IV inhibe edici aktivitesi olan fenilfenantridinler
CA2715683A1 (fr) 1999-08-21 2001-03-01 Nycomed Gmbh Combinaison synergiste
WO2001051470A1 (fr) 2000-01-11 2001-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridine-n-oxydes
WO2002005616A1 (fr) * 2000-07-14 2002-01-24 Altana Pharma Ag Nouvelles 6-phenylphenanthridines
WO2002006239A1 (fr) * 2000-07-14 2002-01-24 Altana Pharma Ag Phenanthridine-n-oxydes
WO2002006238A1 (fr) * 2000-07-14 2002-01-24 Altana Pharma Ag 6-phenylphenanthridines a substitution cycloalkyle ou cycloalkylmethyle
ES2236288T3 (es) 2000-07-14 2005-07-16 Altana Pharma Ag 6-heteroarilfenantridinas.
CA2495597A1 (fr) * 2002-08-17 2004-03-04 Altana Pharma Ag Nouvelles phenanthridines
JP4587294B2 (ja) 2002-08-29 2010-11-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｐｄｅ４インヒビターとしての２−ヒドロキシ−６−フェニルフェナントリジン
ATE353217T1 (de) * 2002-08-29 2007-02-15 Altana Pharma Ag 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
MXPA05005366A (es) 2002-11-20 2005-08-03 Pfizer Prod Inc Un metodo para preparar acido indano-1,3-dicarboxilico.
US7153824B2 (en) 2003-04-01 2006-12-26 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
EP1658270A1 (fr) * 2003-07-31 2006-05-24 ALTANA Pharma AG Nouvelles 6-phenylphenanthridines
CA2533636A1 (fr) * 2003-07-31 2005-02-10 Altana Pharma Ag Nouvelles 6-phenylphenanthridines
CA2556086C (fr) * 2004-02-18 2014-04-01 Altana Pharma Ag Nouveaux hydroxy-6-phenylphenenthridines a substitution guanidinyle efficaces en tant qu'inhibiteurs de la phosphodiesterase (pde) 4
PL2589599T4 (pl) 2004-03-03 2015-06-30 Takeda Gmbh Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
AU2005220034A1 (en) * 2004-03-09 2005-09-15 Nycomed Gmbh Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
EP1725534A1 (fr) * 2004-03-10 2006-11-29 Altana Pharma AG Nouveaux hydroxy-6-phenylphenanthridines amido-substitues et leur utilisation comme inhibiteurs de pde4
CA2558390A1 (fr) * 2004-03-10 2005-09-22 Altana Pharma Ag Nouvelles hydroxy-6-phenylphenanthridines contenant thio et leur utilisation comme inhibiteurs de pde4
WO2005085203A1 (fr) * 2004-03-10 2005-09-15 Altana Pharma Ag Nouvelles hydroxy-6-phenylphenanthridines difluoroethoxy-substituees
PL1856093T3 (pl) * 2005-03-02 2010-05-31 Takeda Gmbh Chlorowodorek (2R,4aR,10bR)-6-(2,6-dimetoksy-pirydyn-3-ylo)-9-etoksy-8-metoksy-1,2,3,4,4a,10b-heksahydrofenantrydyn-2-olu
ES2460897T3 (es) 2007-10-04 2014-05-14 F. Hoffmann-La Roche Ag Derivados de ciclopropil aril amida y usos de los mismos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
BR9707233A (pt) * 1996-01-31 1999-07-20 Byk Gulden Lomberg Chem Fab Fenantridinas
SI0889886T1 (en) * 1996-03-26 2003-02-28 Altana Pharma Ag Novel phenanthridines substituted in the 6 position

Also Published As

Publication number Publication date
PT998460E (pt) 2004-07-30
EP0998460A1 (fr) 2000-05-10
CZ2000282A3 (cs) 2000-08-16
DE69822162D1 (de) 2004-04-08
JP2001510825A (ja) 2001-08-07
IL133824A0 (en) 2001-04-30
HUP0002510A3 (en) 2002-10-28
CA2297923A1 (fr) 1999-02-04
SI0998460T1 (en) 2004-08-31
EE04054B1 (et) 2003-06-16
PL338339A1 (en) 2000-10-23
HUP0002510A2 (hu) 2000-12-28
ATE260899T1 (de) 2004-03-15
US6410551B1 (en) 2002-06-25
CZ293725B6 (cs) 2004-07-14
EP0998460B1 (fr) 2004-03-03
EE200000033A (et) 2000-10-16
AU8977098A (en) 1999-02-16
WO1999005111A1 (fr) 1999-02-04
DE69822162T2 (de) 2005-01-27
ES2217575T3 (es) 2004-11-01
DK0998460T3 (da) 2004-07-05
AU753615B2 (en) 2002-10-24
PL190685B1 (pl) 2005-12-30

Similar Documents

Publication Publication Date Title
IL133824A (en) Tetrazole derivatives and medicaments containing the same
IL144026A0 (en) Phenylphenanthridine derivatives and pharmaceutical compostions containing the same
CY2473B1 (en) New phenanthridines.
IL133825A0 (en) Substituted 6-phenylphenanthridines, medicaments containing same and use thereof
AU2291097A (en) Novel phenanthridines substituted in the 6 position
IL140710A0 (en) Pulmonary delivery of active agents
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
PL341239A1 (en) Dihydrobenzofuranes
SI1147088T1 (sl) 6-arilfenantridini s PDE-IV inhibirajoco aktivnostjo
MX9700813A (es) Nuevos derivados 3-substituidos de 3h-2,3-benzodiazepina, su preparacion y su uso como medicamentos.
AU758194C (en) Novel benzimidazoles and benzoxazoles

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees